Table 1 Clinical characteristics

Age (years)

58.86 ± 2.19

61.58 ± 2.60

Sex (M/F)

11/4

10/5

BMI (kg/m²)

25.69 ± 1.01

29.66 ± 1.28*

Statin use, n (%)

3 (20%)

3 (20%)

Anti-hypertensive agents, n (%)

10 (67%)

9 (60%)

Anti-platelet agents, n (%)

2 (13%)

4 (27%)

Anti- diabetic agents, n (%)

4 (27%)

6 (40%)

Organic Nitrates, n (%)

2 (13%)

3 (20%)

Aspirin, n (%)

5 (33%)

6 (40%)

DM2, n (%)

6 (40%)

8 (53%)

Active smokers, n (%)

3 (20%)

2 (13%)

SBP (mmHg)

122.93 ± 4.26

127.50 ± 5.38

DBP (mmHg)

73.93 ± 3.79

75.33 ± 3.99

Creatinine (mg/dL)

0.86 ± 0.06

0.87 ± 0.07

eGFR (mL/min/1.73 m2)

60.00 ± 0.01

59.80 ± 0.20

TSH (mIU/L)

2.42 ± 0.52

3.33 ± 0.45

T4 (μg/dL)

8.12 ± 0.86

8.12 ± 0.45

T3 (ng/mL)

1.16 ± 0.04

1.14 ± 0.02

Cholesterol (mg/dL)

147.82 ± 13.28

103.08 ± 14.73*

Triglycerides (mg/dL)

99.09 ± 6.49

100.40 ± 6.49

Glucose (mg/dL)

92.84 ± 2.55

106.21 ± 6.19*

HDL-cholesterol (mg/dL)

40.67 ± 3.20

31.32 ± 2.17*

 Free HDL-cholesterol (mg/dL)

10.36 ± 1.71

11.77 ± 1.04

 Esterified HDL-cholesterol (mg/dL)

50.91 ± 5.37

32.84 ± 4.54*

HDL- triglycerides (mg/dL)

29.63 ± 3.13

24.78 ± 1.99

HDL-phospholipids (mg/dL)

70.31 ± 5.04

70.41 ± 5.33

LDL-cholesterol (mg/dL)

98.18 ± 6.65

62.51 ± 4.70*

HDL 2b (%)

17.59 ± 0.82

20.83 ± 1.90

HDL 2a (%)

11.40 ± 0.30

12.25 ± 0.46

HDL 3a (%)

26.82 ± 1.03

27.05 ± 0.40

HDL 3b (%)

18.69 ± 0.40

20.29 ± 0.61*

HDL 3c (%)

24.49 ± 1.31

20.22 ± 1.44*

SYNTAX score

0.00 (0.00–0.00)

10.00 (2.00–44.00)